हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।
ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं
Ioan Mayer
This Biopharmaceutics introduces abecedarian generalities, styles, and advances in the areas of dissolution, immersion, and permeability and their crucial operations in lozenge form performance. Case studies are used to bandy the operations of biopharmaceutic strategies in the development of successful medicines, with a specific focus on the operations of biopharmaceutic strategies in the development of successful medicines. The book presents an intertwined view in linking pharmaceutic to the natural consequences of medicine products and leverages those for decision making in medicine development. The Biopharmaceutics Bracket System (BCS) isn't only a useful tool for carrying quitclaims for in- vivo bioequivalence studies but also for decision making in the discovery and early development of new drugs. Biopharmaceutics is a major branch in pharmaceutical lores which relates between the physicochemical parcels of a drug in capsule form and the pharmacology, toxicology, or clinical response observed after its administration. Drug effectiveness and safety are dependent on the dosing authority. The optimal capsule and dosing intervals can be fairly different for different drugs. Also, for a single drug, the optimal capsule can be different considerably between cases.